Natraj Proteins Board Meeting on May 22, 2026

Natraj Proteins schedules board meeting on May 22, 2026 to approve audited financial results for Q4/FY ended March 31, 2026.
Meeting agenda includes approval of audited financial statements, balance sheet, and statutory audit report.
Trading window for company securities remains closed until 48 hours after results declaration.
Filing made under SEBI LODR Regulation 29(1)(a) and Insider Trading regulations compliance.